Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mexiletine 200mg/5ml oral solution
0203020P0AAAEAE
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 250mg/10ml solution for injection ampoules
0203020P0AAACAC
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 25mg capsules
0203020P0AAAHAH
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 360mg modified-release capsules
0203020P0AAADAD
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 37.5mg/5ml oral solution
0203020P0AAALAL
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 50mg/5ml oral solution
0203020P0AAAKAK
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexiletine 50mg/5ml oral suspension
0203020P0AAAJAJ
|
Mexiletine hydrochloride | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexitil 250mg/10ml solution for injection ampoules
0203020P0BBADAC
|
Mexitil | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexitil 50mg capsules
0203020P0BBAAAA
|
Mexitil | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Mexitil PL Perlongets 360mg capsules
0203020P0BBAEAD
|
Mexitil | Mexiletine hydrochloride | Cardiovascular System | No data available |
|
Midomil 1mg/5ml solution for infusion vials
0207020AABBAAAA
|
Midomil | Isoprenaline hydrochloride | Cardiovascular System | No data available |
|
Midotense 2.5mg tablets
0207020Y0BEAAAE
|
Midotense | Midodrine hydrochloride | Cardiovascular System | No data available |
|
Milrinone 10mg/10ml solution for infusion ampoules
0201020M0AAAAAA
|
Milrinone lactate | Milrinone lactate | Cardiovascular System | No data available |
|
Milrinone 10mg/10ml solution for injection vials
0201020M0AAABAB
|
Milrinone lactate | Milrinone lactate | Cardiovascular System | No data available |
|
Minipress 2mg tablets
0205040S0BCABAD
|
Minipress | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Minipress 5mg tablets
0205040S0BCACAE
|
Minipress | Prazosin hydrochloride | Cardiovascular System | No data available |
|
Modisal 60 XL tablets
0206010K0BCAAAE
|
Modisal | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Modisal LA25 capsules
0206010K0BCABAH
|
Modisal | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Modisal LA50 capsules
0206010K0BCACAF
|
Modisal | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Moducren tablets
020400030BBAAAA
|
Moducren | Timolol with diuretic | Cardiovascular System | No data available |
|
Moduret 25 tablets
0202040C0BIAAAB
|
Moduret 25 | Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | Cardiovascular System | No data available |
|
Moexipril 15mg tablets
0205051C0AAABAB
|
Moexipril hydrochloride | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Moexipril 7.5mg tablets
0205051C0AAAAAA
|
Moexipril hydrochloride | Moexipril hydrochloride | Cardiovascular System | No data available |
|
Monigen XL 60 tablets
0206010K0CJAAAE
|
Monigen | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Monit 20mg tablets
0206010K0BEAAAC
|
Monit | Isosorbide mononitrate | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.